Key facts
- iOR Partners’s last known valuation is $64.5M (Mar 2025).
- It has raised $19.8M; the latest was PE Growth/Expansion ($2.5M) in Mar 2025.
- Notable investors include C3 Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for iOR Partners
- ·The full record, as it builds
Funding rounds
No funding rounds for iOR Partners are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About iOR Partners
Provider of office-based surgery services to the ophthalmology industry. The company offers planning, development, operations, and support for the entire process from initial planning through ongoing support with all safety and compliance, there helping surgeons control their schedule, increase revenue, and grow their practice.
- Sector
- Healthcare
- HQ
- Kansas City, MO, United States
- Founded
- 2018
- Employees
- 40
- Website
- iorpartners.com/
- Ownership
- Privately Held (backing)
iOR Partners doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in iOR Partners shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on iOR Partners in its N-PORT filings yet. We sweep new filings monthly.